Page 75 - Pagetit
P. 75

NEUROSCIENCE OF PSYCHOACTIVE SUBSTANCE USE AND DEPENDENCE




                             There is a large body of data showing that sensitization is associated with
                          marked changes in the mesolimbic dopamine system. There are both
                          presynaptic changes (increased dopamine release) and postsynaptic changes
                          (changes in receptor sensitivity). In addition, structural changes in output
                          neurons in the nucleus accumbens and prefrontal cortex have also been seen
                          following sensitization to amphetamine and cocaine (Robinson & Kolb, 1997;
                          1999).

                          Sensitization and tolerance

                          It is important at this point to emphasize again that this discussion focuses
                          on sensitization of the mesolimbic dopamine system, i.e. the increase in
                          dopamine in the nucleus accumbens that is observed on repeated drug
                          presentations, and that has been reported for psychoactive substances of all
                          classes.
                             Tolerance can be defined as a given drug producing a decreasing effect
                          with repeated dosing, or when larger doses must be administered to produce
                          the same effect (Jaffe, 1985, 1990). There is differential tolerance to
                          psychomotor stimulants, meaning that tolerance develops to some of the
                          drug effects, but not to others. Indeed, as will be discussed, some drug effects
                          are increased upon repeated drug use. In humans, rapid tolerance develops
                          to the anorexic effects and the lethal effects of amphetamine and cocaine
                          (Angrist & Sudilovsky, 1978; Hoffman & Lefkowitz, 1990). However, no
                          tolerance or change in sensitivity of behavioural responses was observed after
                          repeated daily oral doses of 10 mg of D-amphetamine (Johanson, Kilgore
                          &Uhlenhuth, 1983). Similarly, no tolerance developed to the subjective “high”
                          after repeated daily oral doses of 10 mg of methamphetamin, but tolerance
                          did develop to the cardiovascular effects with repeated daily dosing (Perez-
                          Reyes et al., 1991). Some acute tolerance appears to develop to the
                          cardiovascular effects of cocaine even over a 4-hour infusion period (Ambre
                          et al., 1988). Subjective, behavioural and cardiovascular effects also decline
                          after sequential oral doses of D-amphetamine, despite substantial plasma
                          levels, also suggesting acute tolerance (Angrist et al., 1987). Tolerance does
                          not develop to the stereotyped behaviour and psychosis induced by
                          stimulants, and in fact these behavioural effects appear to show sensitization
                          or an increase with repeated administration (Post et al., 1992). Similar results
                          have been observed in animal studies, with tolerance developing to the
                          anorexic and lethal effects of amphetamine but not to stereotyped behaviour
                          (Lewander, 1974). The same is also true of tolerance to nicotine, alcohol and
                          benzodiazepines, which develops to some drug effects but not others.
                          Tolerance to specific classes of psychoactive substances will be discussed
                          further in Chapter 4.
                             Tolerance can also develop as a result of metabolic enzyme induction, i.e.
                          enzymes that are involved in the metabolism of a drug can increase their
                          activity in the presence of increasing concentrations of the drug. The

                                                          54




                  Chapter_3                54                              19.1.2004, 11:37
   70   71   72   73   74   75   76   77   78   79   80